Urinary exosomes as promising biomarkers for early kidney disease detection.

IF 1.5 Q3 UROLOGY & NEPHROLOGY
American journal of clinical and experimental urology Pub Date : 2025-02-15 eCollection Date: 2025-01-01 DOI:10.62347/DAKE5842
An-Ping Liu, Tian-Jing Sun, Tong-Ying Liu, Hai-Zhen Duan, Xu-Heng Jiang, Mo Li, Yuan-Ze Luo, Michael P Feloney, Mark Cline, Yuan-Yuan Zhang, An-Yong Yu
{"title":"Urinary exosomes as promising biomarkers for early kidney disease detection.","authors":"An-Ping Liu, Tian-Jing Sun, Tong-Ying Liu, Hai-Zhen Duan, Xu-Heng Jiang, Mo Li, Yuan-Ze Luo, Michael P Feloney, Mark Cline, Yuan-Yuan Zhang, An-Yong Yu","doi":"10.62347/DAKE5842","DOIUrl":null,"url":null,"abstract":"<p><p>Kidney injury and disease pose a significant global health burden. Despite existing diagnostic methods, early detection remains challenging due to the lack of specific molecular markers to identify and stage various kidney lesions. Urinary exosomes, extracellular vesicles secreted by kidney cells, offer a promising solution. These vesicles contain a variety of biomolecules, such as proteins, RNA, and DNA. These biomolecules can reflect the unique physiological and pathological states of the kidney. This review explores the potential of urinary exosomes as biomarkers for a range of kidney diseases, including renal failure, diabetic nephropathy, and renal tumors. By analyzing specific protein alterations within these exosomes, we aim to develop more precise and tailored diagnostic tools to detect kidney diseases at an early stage and improve patient outcomes. While challenges persist in isolating, characterizing, and extracting reliable information from urinary exosomes, overcoming these hurdles is crucial for advancing their clinical application. The successful implementation of urinary exosome-based diagnostics could revolutionize early kidney disease detection, enabling more targeted treatment and improved patient outcomes.</p>","PeriodicalId":7438,"journal":{"name":"American journal of clinical and experimental urology","volume":"13 1","pages":"1-19"},"PeriodicalIF":1.5000,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11928825/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of clinical and experimental urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.62347/DAKE5842","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Kidney injury and disease pose a significant global health burden. Despite existing diagnostic methods, early detection remains challenging due to the lack of specific molecular markers to identify and stage various kidney lesions. Urinary exosomes, extracellular vesicles secreted by kidney cells, offer a promising solution. These vesicles contain a variety of biomolecules, such as proteins, RNA, and DNA. These biomolecules can reflect the unique physiological and pathological states of the kidney. This review explores the potential of urinary exosomes as biomarkers for a range of kidney diseases, including renal failure, diabetic nephropathy, and renal tumors. By analyzing specific protein alterations within these exosomes, we aim to develop more precise and tailored diagnostic tools to detect kidney diseases at an early stage and improve patient outcomes. While challenges persist in isolating, characterizing, and extracting reliable information from urinary exosomes, overcoming these hurdles is crucial for advancing their clinical application. The successful implementation of urinary exosome-based diagnostics could revolutionize early kidney disease detection, enabling more targeted treatment and improved patient outcomes.

尿外泌体作为早期肾脏疾病检测的有前途的生物标志物
肾脏损伤和疾病构成了重大的全球健康负担。尽管现有的诊断方法,由于缺乏特异性的分子标记物来识别和分期各种肾脏病变,早期检测仍然具有挑战性。尿外泌体是由肾细胞分泌的细胞外囊泡,它提供了一个有希望的解决方案。这些囊泡含有多种生物分子,如蛋白质、RNA和DNA。这些生物分子可以反映肾脏独特的生理和病理状态。这篇综述探讨了尿外泌体作为一系列肾脏疾病的生物标志物的潜力,包括肾衰竭、糖尿病肾病和肾肿瘤。通过分析这些外泌体中的特定蛋白质改变,我们的目标是开发更精确和量身定制的诊断工具,以在早期阶段检测肾脏疾病并改善患者的预后。尽管从尿外泌体中分离、表征和提取可靠信息的挑战仍然存在,但克服这些障碍对于推进其临床应用至关重要。基于尿外泌体的诊断的成功实施可能会彻底改变早期肾脏疾病的检测,使更有针对性的治疗和改善患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
8.30%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信